Clinical trial

Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)

NCT03748550

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-04-29

PhaseNA

Study timeline

Study start (actual)2019-04-29Date precision: day

Registry last updated2024-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancer, Breastunresolved

Cardiotoxicityunresolved

Cardiovascular Diseasesunresolved

Interventions

Aerobic exerciseBEHAVIORAL

Sponsors & collaborators

Nova Scotia Health Authoritylead sponsor

Canadian Cancer Society (CCS)collaborator

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

WinnipegManitoba, Canada1 HalifaxNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03748550 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.